A Phase II Trial of Haptaplatin/5-FU and Leucovorin for Advanced Stomach Cancer

PURPOSE: Heptaplatin (SKI-2053 R) is a new platinum analogue, with a better toxicity profile than cisplatin, and has antitumor activity even in cisplatin resistant cell lines. 5-fluoruracil (5-FU) has shown synergy with platinum compounds. This phase II trial was designed to determine the efficacy a...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Lee, Won Sup, Lee, Gyeong-Won, Kim, Hwal Woong, Lee, Ok-Jae, Lee, Young-Joon, Ko, Gyung Hyuck, Lee, Jong-Seok, Jang, Joung Soon, Ha, Woo Song
Формат: Artigo
Язык:Inglês
Опубликовано: Korean Cancer Association 2005
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2785922/
https://ncbi.nlm.nih.gov/pubmed/19956515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2005.37.4.208
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы